Here we demonstrate that GSK3 inhibition in NK cells results in increased TNF-α production by these cells, which upregulates ICAM-1 on AML cells and results in increased NK-AML conjugate formation resulting in enhanced killing of AML cells. Here, ICAM1 is linked to acute myeloid leukemia.